European Innovation Council

Founded in Madrid, Spain in 2014, Wooptix develops innovative imaging technologies. The company specializes in creating three-dimensional modulation of images for enhanced volumetric photography and videography, enabling advanced image post-processing.

Inbrain Neuroelectronics is a medical device company that designs and commercializes graphene-based neural interfaces and intelligent neuromodulation systems to treat brain disorders. The core platform is an implantable system that decodes brain activity with high resolution and provides focal, adaptive stimulation, enabling real-time precision neurology and autonomous therapy adjustments. This approach aims to maximize therapeutic outcomes while minimizing side effects for conditions such as Parkinson’s disease, epilepsy, and stroke rehabilitation. The company pursues strategic collaborations to extend its solutions to peripheral nerve and systemic disease applications, expanding the potential of neurotechnology and bioelectronics.

Ability Pharmaceuticals is a drug discovery and development company based in Barcelona, Spain. It develops human therapeutics targeting cell membranes to treat cancer and other indications with unmet medical needs. Ability Pharmaceuticals is focused on developing new drugs for the treatment of lung cancer and pancreatic cancer. The company develops Lipid Analogue Therapeutics, a new drug class that modifies the composition of the cell membrane and displays a capacity to influence the local organization of lipid structures in the cell membrane, inducing the formation of non-lamellar phase structures. Its development pipeline includes ABTL0812 product in preclinical development; and ABTL1014, a drug candidate in preclinical characterization.

Founded in 2019 with headquarters in San Sebastian, Spain, Multiverse Computing develops quantum computing software tailored to solve complex real-world challenges. Its software leverages probabilistic technology for portfolio optimization, risk analysis, and market simulation, serving clients across industries such as finance, energy, manufacturing, and logistics.

Daze is an engineering startup focused on creating innovative solutions for electric vehicle charging. Its flagship product, DazePlug, is an automatic charging device that utilizes smart charging ecosystems and energy management systems. This technology enables automatic inductive charging, significantly reducing the time required to charge electric vehicles while eliminating the need for manual handling of cables. DazePlug features a retrofit design that is both waterproof and dustproof, ensuring durability and ease of use. By simplifying the charging process, Daze aims to enhance user experience and convenience for electric vehicle owners.

Palobiofarma is a Spanish biotechnology company based in Barcelona, focused on discovering and developing new medicines by modulating adenosine receptors. It aims to be a leader in European adenosine receptor drug discovery, using medicinal chemistry and in vitro pharmacology to identify selective adenosine receptor modulators, with potential applications in treating advanced prostate cancer.

Founded in 2015, Ignion specializes in designing and manufacturing antennas tailored for mobile and wireless connectivity. Their off-the-shelf antennas cater to Internet of Things devices, mobile connectivity, and short-range wireless systems, facilitating seamless integration within industrial designs.

Inbrain Neuroelectronics is a medical device company that designs and commercializes graphene-based neural interfaces and intelligent neuromodulation systems to treat brain disorders. The core platform is an implantable system that decodes brain activity with high resolution and provides focal, adaptive stimulation, enabling real-time precision neurology and autonomous therapy adjustments. This approach aims to maximize therapeutic outcomes while minimizing side effects for conditions such as Parkinson’s disease, epilepsy, and stroke rehabilitation. The company pursues strategic collaborations to extend its solutions to peripheral nerve and systemic disease applications, expanding the potential of neurotechnology and bioelectronics.

Founded in Madrid, Spain in 2014, Wooptix develops innovative imaging technologies. The company specializes in creating three-dimensional modulation of images for enhanced volumetric photography and videography, enabling advanced image post-processing.

Founded in Madrid, Spain in 2014, Wooptix develops innovative imaging technologies. The company specializes in creating three-dimensional modulation of images for enhanced volumetric photography and videography, enabling advanced image post-processing.

ADmit Therapeutics is a biotechnology company that develops diagnostic tests for early detection of Alzheimer’s disease. Its blood-based assay uses epigenetic analysis to assess mitochondrial DNA methylation, including methylcytosines, through next-generation sequencing, and does not rely on beta-amyloid or tau markers. The test is intended to aid pharmaceutical research by enabling early diagnosis and streamlined drug development. The company was founded in 2017 and is based in Begues, Spain.

Daze is an engineering startup focused on creating innovative solutions for electric vehicle charging. Its flagship product, DazePlug, is an automatic charging device that utilizes smart charging ecosystems and energy management systems. This technology enables automatic inductive charging, significantly reducing the time required to charge electric vehicles while eliminating the need for manual handling of cables. DazePlug features a retrofit design that is both waterproof and dustproof, ensuring durability and ease of use. By simplifying the charging process, Daze aims to enhance user experience and convenience for electric vehicle owners.

ELEM Biotech SL is a biomedical software company based in Barcelona, Spain, that specializes in creating virtual human models through advanced mathematical modeling and cloud computing. Founded in 2018 by researchers from the Barcelona Supercomputing Center, ELEM has developed a suite of simulation tools known as Alya Red. This platform operates on a Software-as-a-Service model and is designed for the medical device and pharmaceutical industries. Alya Red allows for the simulation of cardiovascular and respiratory systems on virtual patients, utilizing high-performance computing, computational biomechanics, and data analysis. These virtual avatars enable biomedical companies and healthcare professionals to enhance diagnostics, plan treatments, optimize drug delivery, and improve medical devices.

Inbrain Neuroelectronics is a medical device company that designs and commercializes graphene-based neural interfaces and intelligent neuromodulation systems to treat brain disorders. The core platform is an implantable system that decodes brain activity with high resolution and provides focal, adaptive stimulation, enabling real-time precision neurology and autonomous therapy adjustments. This approach aims to maximize therapeutic outcomes while minimizing side effects for conditions such as Parkinson’s disease, epilepsy, and stroke rehabilitation. The company pursues strategic collaborations to extend its solutions to peripheral nerve and systemic disease applications, expanding the potential of neurotechnology and bioelectronics.

Inbrain Neuroelectronics is a medical device company that designs and commercializes graphene-based neural interfaces and intelligent neuromodulation systems to treat brain disorders. The core platform is an implantable system that decodes brain activity with high resolution and provides focal, adaptive stimulation, enabling real-time precision neurology and autonomous therapy adjustments. This approach aims to maximize therapeutic outcomes while minimizing side effects for conditions such as Parkinson’s disease, epilepsy, and stroke rehabilitation. The company pursues strategic collaborations to extend its solutions to peripheral nerve and systemic disease applications, expanding the potential of neurotechnology and bioelectronics.

ELEM Biotech SL is a biomedical software company based in Barcelona, Spain, that specializes in creating virtual human models through advanced mathematical modeling and cloud computing. Founded in 2018 by researchers from the Barcelona Supercomputing Center, ELEM has developed a suite of simulation tools known as Alya Red. This platform operates on a Software-as-a-Service model and is designed for the medical device and pharmaceutical industries. Alya Red allows for the simulation of cardiovascular and respiratory systems on virtual patients, utilizing high-performance computing, computational biomechanics, and data analysis. These virtual avatars enable biomedical companies and healthcare professionals to enhance diagnostics, plan treatments, optimize drug delivery, and improve medical devices.

Abzu is a company that develops a scientific artificial intelligence platform aimed at accelerating drug discovery and bringing pharmaceuticals to market more efficiently. Founded in January 2018, with offices in Copenhagen, Denmark, and Barcelona, Spain, Abzu challenges traditional, opaque AI methods by utilizing its pioneering technology, the QLattice. This platform provides transparent and explainable models that enable data scientists to approach their work with a scientific mindset. By unlocking new disease mechanisms, discovering novel biomarkers, and designing improved drugs, Abzu empowers pharmaceutical and biotech companies to validate multiple targets simultaneously, thereby enhancing their research capabilities and reducing development costs.

SiPearl is a French semiconductor company specializing in designing high-performance, low-power microprocessors for exascale supercomputers. Its flagship product, Rhea, based on Arm Neoverse V1 architecture and manufactured using TSMC's N6 or better processes, aims to advance computing infrastructure for critical applications such as HPC, AI, and data centers.

SiPearl is a French semiconductor company specializing in designing high-performance, low-power microprocessors for exascale supercomputers. Its flagship product, Rhea, based on Arm Neoverse V1 architecture and manufactured using TSMC's N6 or better processes, aims to advance computing infrastructure for critical applications such as HPC, AI, and data centers.

Founded in 2016, SAALG Geomechanics specializes in real-time ground analysis software for civil works and building projects. It offers machine learning-driven solutions to anticipate ground movement issues, along with numerical models calibrations, soil parameter characterization, and geotechnical consulting services.

Founded in 2015, Ignion specializes in designing and manufacturing antennas tailored for mobile and wireless connectivity. Their off-the-shelf antennas cater to Internet of Things devices, mobile connectivity, and short-range wireless systems, facilitating seamless integration within industrial designs.

Founded in 2016, SAALG Geomechanics specializes in real-time ground analysis software for civil works and building projects. It offers machine learning-driven solutions to anticipate ground movement issues, along with numerical models calibrations, soil parameter characterization, and geotechnical consulting services.

Founded in 2015, Ignion specializes in designing and manufacturing antennas tailored for mobile and wireless connectivity. Their off-the-shelf antennas cater to Internet of Things devices, mobile connectivity, and short-range wireless systems, facilitating seamless integration within industrial designs.

Founded in 2019 with headquarters in San Sebastian, Spain, Multiverse Computing develops quantum computing software tailored to solve complex real-world challenges. Its software leverages probabilistic technology for portfolio optimization, risk analysis, and market simulation, serving clients across industries such as finance, energy, manufacturing, and logistics.

Founded in 2019 with headquarters in San Sebastian, Spain, Multiverse Computing develops quantum computing software tailored to solve complex real-world challenges. Its software leverages probabilistic technology for portfolio optimization, risk analysis, and market simulation, serving clients across industries such as finance, energy, manufacturing, and logistics.

Aortyx is a pioneering company founded by researchers from IQS School of Engineering and Hospital Clínic de Barcelona. It specializes in developing endovascular devices designed to treat aortic diseases, focusing on tissue regeneration through mimicking the aorta's biomechanical environment.

Carto is a location intelligence platform that turns spatial data into actionable insights for logistics, marketing, and site optimization. The cloud-based mapping, analysis, and visualization engine enables data scientists, developers, and analysts to treat location as an active analytical dimension, solving spatial problems, optimizing business processes, and predicting outcomes. Founded in 2012 and headquartered in New York City, Carto operates with offices in Madrid, Seville, and Washington, DC, and serves thousands of customers worldwide, including Mastercard, Vodafone, Bain & Company, and Coca-Cola, with hundreds of thousands of users. The company is backed by leading venture investors Accel Partners, Salesforce Ventures, Earlybird Ventures, and Kibo Ventures, underscoring its position in location intelligence.

Daze is an engineering startup focused on creating innovative solutions for electric vehicle charging. Its flagship product, DazePlug, is an automatic charging device that utilizes smart charging ecosystems and energy management systems. This technology enables automatic inductive charging, significantly reducing the time required to charge electric vehicles while eliminating the need for manual handling of cables. DazePlug features a retrofit design that is both waterproof and dustproof, ensuring durability and ease of use. By simplifying the charging process, Daze aims to enhance user experience and convenience for electric vehicle owners.

Founded in Madrid, Spain in 2014, Wooptix develops innovative imaging technologies. The company specializes in creating three-dimensional modulation of images for enhanced volumetric photography and videography, enabling advanced image post-processing.

Palobiofarma is a Spanish biotechnology company based in Barcelona, focused on discovering and developing new medicines by modulating adenosine receptors. It aims to be a leader in European adenosine receptor drug discovery, using medicinal chemistry and in vitro pharmacology to identify selective adenosine receptor modulators, with potential applications in treating advanced prostate cancer.

Palobiofarma is a Spanish biotechnology company based in Barcelona, focused on discovering and developing new medicines by modulating adenosine receptors. It aims to be a leader in European adenosine receptor drug discovery, using medicinal chemistry and in vitro pharmacology to identify selective adenosine receptor modulators, with potential applications in treating advanced prostate cancer.

SiPearl is a French semiconductor company specializing in designing high-performance, low-power microprocessors for exascale supercomputers. Its flagship product, Rhea, based on Arm Neoverse V1 architecture and manufactured using TSMC's N6 or better processes, aims to advance computing infrastructure for critical applications such as HPC, AI, and data centers.

Founded in Madrid, Spain in 2014, Wooptix develops innovative imaging technologies. The company specializes in creating three-dimensional modulation of images for enhanced volumetric photography and videography, enabling advanced image post-processing.

MYSPHERA SL is a company based in Paterna, Spain, that specializes in developing location and process visibility solutions for the healthcare sector using Internet of Things (IoT) technology and real-time location systems (RTLS). Established in 2012, MYSPHERA offers a range of IoT devices and applications designed to enhance patient care and operational efficiency in acute care hospitals, senior living facilities, and patient homes. Its solutions include tracking systems for residents and nursing services, as well as alerts for patients. The company also provides various web applications, such as MYHOSPITAL, MYNURSING, and MYLOCS, which assist healthcare professionals and administrators in managing services effectively. By delivering actionable insights through smart sensors, MYSPHERA aims to improve patient outcomes and optimize resource management across healthcare organizations in Europe, the Middle East, and Latin America.

SiPearl is a French semiconductor company specializing in designing high-performance, low-power microprocessors for exascale supercomputers. Its flagship product, Rhea, based on Arm Neoverse V1 architecture and manufactured using TSMC's N6 or better processes, aims to advance computing infrastructure for critical applications such as HPC, AI, and data centers.

MYSPHERA SL is a company based in Paterna, Spain, that specializes in developing location and process visibility solutions for the healthcare sector using Internet of Things (IoT) technology and real-time location systems (RTLS). Established in 2012, MYSPHERA offers a range of IoT devices and applications designed to enhance patient care and operational efficiency in acute care hospitals, senior living facilities, and patient homes. Its solutions include tracking systems for residents and nursing services, as well as alerts for patients. The company also provides various web applications, such as MYHOSPITAL, MYNURSING, and MYLOCS, which assist healthcare professionals and administrators in managing services effectively. By delivering actionable insights through smart sensors, MYSPHERA aims to improve patient outcomes and optimize resource management across healthcare organizations in Europe, the Middle East, and Latin America.

Inbrain Neuroelectronics is a medical device company that designs and commercializes graphene-based neural interfaces and intelligent neuromodulation systems to treat brain disorders. The core platform is an implantable system that decodes brain activity with high resolution and provides focal, adaptive stimulation, enabling real-time precision neurology and autonomous therapy adjustments. This approach aims to maximize therapeutic outcomes while minimizing side effects for conditions such as Parkinson’s disease, epilepsy, and stroke rehabilitation. The company pursues strategic collaborations to extend its solutions to peripheral nerve and systemic disease applications, expanding the potential of neurotechnology and bioelectronics.

Daze is an engineering startup focused on creating innovative solutions for electric vehicle charging. Its flagship product, DazePlug, is an automatic charging device that utilizes smart charging ecosystems and energy management systems. This technology enables automatic inductive charging, significantly reducing the time required to charge electric vehicles while eliminating the need for manual handling of cables. DazePlug features a retrofit design that is both waterproof and dustproof, ensuring durability and ease of use. By simplifying the charging process, Daze aims to enhance user experience and convenience for electric vehicle owners.

X1 Wind is a company based in Barcelona, Spain, specializing in the development of innovative floating wind platforms for deep-water offshore wind energy. Founded in 2017, X1 Wind has engineered its platform to achieve a significant reduction in both cost and weight—by 50 percent and 80 percent, respectively—compared to traditional floating wind systems. The design features fewer active systems than current alternatives, allowing for simplified installation that can be completed at the port and transported to the site using a small tugboat. This approach not only enhances operational depth range but also improves scalability and reduces maintenance requirements. By focusing on these advancements, X1 Wind aims to provide a clean, affordable energy solution while contributing to global efforts to lower carbon emissions.

Unblur is a technology company that develops an incident command platform for public emergency services, providing real-time situational awareness and centralized data and tools to support incident commanders. Its modular SaaS platform, IRIS, is designed to coordinate responders, streamline decision-making, and improve operational response at all stages of an incident. Founded in 2015, Unblur is headquartered in Barcelona, Spain.

Unblur is a technology company that develops an incident command platform for public emergency services, providing real-time situational awareness and centralized data and tools to support incident commanders. Its modular SaaS platform, IRIS, is designed to coordinate responders, streamline decision-making, and improve operational response at all stages of an incident. Founded in 2015, Unblur is headquartered in Barcelona, Spain.

Ability Pharmaceuticals is a drug discovery and development company based in Barcelona, Spain. It develops human therapeutics targeting cell membranes to treat cancer and other indications with unmet medical needs. Ability Pharmaceuticals is focused on developing new drugs for the treatment of lung cancer and pancreatic cancer. The company develops Lipid Analogue Therapeutics, a new drug class that modifies the composition of the cell membrane and displays a capacity to influence the local organization of lipid structures in the cell membrane, inducing the formation of non-lamellar phase structures. Its development pipeline includes ABTL0812 product in preclinical development; and ABTL1014, a drug candidate in preclinical characterization.

ADmit Therapeutics is a biotechnology company that develops diagnostic tests for early detection of Alzheimer’s disease. Its blood-based assay uses epigenetic analysis to assess mitochondrial DNA methylation, including methylcytosines, through next-generation sequencing, and does not rely on beta-amyloid or tau markers. The test is intended to aid pharmaceutical research by enabling early diagnosis and streamlined drug development. The company was founded in 2017 and is based in Begues, Spain.

Carto is a location intelligence platform that turns spatial data into actionable insights for logistics, marketing, and site optimization. The cloud-based mapping, analysis, and visualization engine enables data scientists, developers, and analysts to treat location as an active analytical dimension, solving spatial problems, optimizing business processes, and predicting outcomes. Founded in 2012 and headquartered in New York City, Carto operates with offices in Madrid, Seville, and Washington, DC, and serves thousands of customers worldwide, including Mastercard, Vodafone, Bain & Company, and Coca-Cola, with hundreds of thousands of users. The company is backed by leading venture investors Accel Partners, Salesforce Ventures, Earlybird Ventures, and Kibo Ventures, underscoring its position in location intelligence.

ADmit Therapeutics is a biotechnology company that develops diagnostic tests for early detection of Alzheimer’s disease. Its blood-based assay uses epigenetic analysis to assess mitochondrial DNA methylation, including methylcytosines, through next-generation sequencing, and does not rely on beta-amyloid or tau markers. The test is intended to aid pharmaceutical research by enabling early diagnosis and streamlined drug development. The company was founded in 2017 and is based in Begues, Spain.

AEInnova develops autonomous industrial monitoring devices for predictive maintenance. Its flagship device InduEye is battery-free, self-powered, and capable of edge computing for real-time vibration, thermal, and steam-trap monitoring, powered by waste heat with optional solar or wind energy. It uses LoRaWAN or NB-IoT/LTE-CAT M for communications and streams data to cloud dashboards with analytics, alarms, and environmental impact analysis. The system aims to reduce downtime and maintenance costs through non-invasive, self-sustaining monitoring. Certifications include CE and ATEX/IECEX, with FCC ongoing. The technology is deployed across sectors such as oil and gas, aluminium, steel, paper, rubber, water treatment, and energy, with customers including Repsol, Cepsa, ArcelorMittal, Enel, and others. AEInnova has been recognized as a leading EU scale-up with multiple awards and EC funding, and participates in EU R&D initiatives related to energy harvesting and high-temperature IoT.

Ability Pharmaceuticals is a drug discovery and development company based in Barcelona, Spain. It develops human therapeutics targeting cell membranes to treat cancer and other indications with unmet medical needs. Ability Pharmaceuticals is focused on developing new drugs for the treatment of lung cancer and pancreatic cancer. The company develops Lipid Analogue Therapeutics, a new drug class that modifies the composition of the cell membrane and displays a capacity to influence the local organization of lipid structures in the cell membrane, inducing the formation of non-lamellar phase structures. Its development pipeline includes ABTL0812 product in preclinical development; and ABTL1014, a drug candidate in preclinical characterization.

AEInnova develops autonomous industrial monitoring devices for predictive maintenance. Its flagship device InduEye is battery-free, self-powered, and capable of edge computing for real-time vibration, thermal, and steam-trap monitoring, powered by waste heat with optional solar or wind energy. It uses LoRaWAN or NB-IoT/LTE-CAT M for communications and streams data to cloud dashboards with analytics, alarms, and environmental impact analysis. The system aims to reduce downtime and maintenance costs through non-invasive, self-sustaining monitoring. Certifications include CE and ATEX/IECEX, with FCC ongoing. The technology is deployed across sectors such as oil and gas, aluminium, steel, paper, rubber, water treatment, and energy, with customers including Repsol, Cepsa, ArcelorMittal, Enel, and others. AEInnova has been recognized as a leading EU scale-up with multiple awards and EC funding, and participates in EU R&D initiatives related to energy harvesting and high-temperature IoT.

AEInnova develops autonomous industrial monitoring devices for predictive maintenance. Its flagship device InduEye is battery-free, self-powered, and capable of edge computing for real-time vibration, thermal, and steam-trap monitoring, powered by waste heat with optional solar or wind energy. It uses LoRaWAN or NB-IoT/LTE-CAT M for communications and streams data to cloud dashboards with analytics, alarms, and environmental impact analysis. The system aims to reduce downtime and maintenance costs through non-invasive, self-sustaining monitoring. Certifications include CE and ATEX/IECEX, with FCC ongoing. The technology is deployed across sectors such as oil and gas, aluminium, steel, paper, rubber, water treatment, and energy, with customers including Repsol, Cepsa, ArcelorMittal, Enel, and others. AEInnova has been recognized as a leading EU scale-up with multiple awards and EC funding, and participates in EU R&D initiatives related to energy harvesting and high-temperature IoT.

X1 Wind is a company based in Barcelona, Spain, specializing in the development of innovative floating wind platforms for deep-water offshore wind energy. Founded in 2017, X1 Wind has engineered its platform to achieve a significant reduction in both cost and weight—by 50 percent and 80 percent, respectively—compared to traditional floating wind systems. The design features fewer active systems than current alternatives, allowing for simplified installation that can be completed at the port and transported to the site using a small tugboat. This approach not only enhances operational depth range but also improves scalability and reduces maintenance requirements. By focusing on these advancements, X1 Wind aims to provide a clean, affordable energy solution while contributing to global efforts to lower carbon emissions.